Pharmaceuticals, Biotechnology and Life Sciences
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cadent Therapeutics, a company focused on the development of therapies to improve the lives of patients with movement,…
— Promotions, new appointments and relocations within the investment team — — Expansion of Ridgeline laboratories in Basel — SAN…
New company site will focus on creating next-gen product candidates to break barriers in the treatment of solid tumors PHILADELPHIA–(BUSINESS…
– BT1718 on track for Phase IIa initiation in 2020; BT5528 Phase I dose escalation is ongoing; BT8009 on track…
DUBLIN–(BUSINESS WIRE)–The “Aptamers – Market Analysis, Trends, and Forecasts” report has been added to ResearchAndMarkets.com’s offering. Aptamers market worldwide is…
BOSTON–(BUSINESS WIRE)–Gelesis, a biotechnology company developing a novel hydrogel platform technology to treat obesity and other chronic diseases related to…
DENVER–(BUSINESS WIRE)–Excellere Partners, a Denver-based private equity firm focused on partnering with entrepreneurs and management teams, announced today that it…
-Cooperation in Product Development for Innovative Cardiac Regenerative Medicine- TOKYO–(BUSINESS WIRE)–#biotech–Tokyo-based Heartseed Inc. (“Heartseed”), a Keio University-originated biotechnology company developing…
TOKYO–(BUSINESS WIRE)–#biotech–Heartseed Inc. (hereinafter Heartseed), a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes for the treatment of heart failure (HF), today…
SAN DIEGO–(BUSINESS WIRE)–AntiCancer Inc. has announced that its methionine-cleaving enzyme methioninase prevented mice from becoming obese while on an ultra-high…